The modified light chain of inter-alpha inhibitor/antibody fusion protein, MR1007, improves survival in the rabbit sepsis models

od Nakamura, Masaki, Takeuchi, Takashi, Yatagai, Yukiko, Naito, Katsuki, Shirakawa, Kamon, Hosaka, Yoshitaka, Furusako, Shoji
Izdano 2007

In vivo Antitumor Mechanism of Natural Human Tumor Necrosis Factor Involving a T Cell‐mediated Immunological Route

od Asami, Tetsuya, Imai, Meroni, Tanaka, Yasuo, Hosaka, Yoshitaka, Kato, Kazuharu, Nakamura, Norio, Horisawa, Yoshifumi, Ashida, Yoshikazu, Kanamori, Toshinori, Nobuhara, Masahiro, Kurimoto, Masashi
Izdano u Jpn J Cancer Res (1989)

A novel free fatty acid receptor 1 (GPR40/FFAR1) agonist, MR1704, enhances glucose‐dependent insulin secretion and improves glucose homeostasis in rats

od Tsuda, Naoto, Kawaji, Atsuko, Sato, Toshihiro, Takagi, Mitsuhiro, Higashi, Chika, Kato, Yutaka, Ogawa, Kumiko, Naba, Hiroyasu, Ohkouchi, Munetaka, Nakamura, Masaki, Hosaka, Yoshitaka, Sakaki, Junichi
Izdano u Pharmacol Res Perspect (2017)

A novel antiplatelet antibody therapy that induces cAMP-dependent endocytosis of the GPVI/Fc receptor γ-chain complex

od Takayama, Hiroshi, Hosaka, Yoshitaka, Nakayama, Kazuyuki, Shirakawa, Kamon, Naitoh, Katsuki, Matsusue, Tomokazu, Shinozaki, Mikihiko, Honda, Motoyasu, Yatagai, Yukiko, Kawahara, Tetsushi, Hirose, Jiro, Yokoyama, Tooru, Kurihara, Michiru, Furusako, Shoji
Izdano 2008